Dehydroepiandrosterone decreases behavioral despair in high- but not low-anxiety rats

Physiology and Behavior

Volumn 62, Issue 5, 1997, Pages 1053-1057

  Prasad, Amit ^a   Imamura, Makoto ^a   Prasad, Chandan ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Anxiety depression; Dehydroepiandrosterone; Elevated plus maze; Mixed anxiety depression; Porsolt's test

Indexed keywords

CORTICOSTERONE; PRASTERONE;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030867394     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(97)00239-4     Document Type: Article

References (33)

1. Barden, N.; Reul, J. M.; Holsboer, F. Do antidepressants stabilize mood through actions on the hypothalamo-pituitary-adrenocortical system? Trends Neurosci. 18:6-11; 1995.
2. Bond, S.; Brock, J.; Ross, K.; Prasad, C. Strain related differences in anxiety levels are reflected in behavioral performance of naive Lewis and Fischer rats (abstr). Clin. Res. 41:790A; 1993.
3. Butler, P. D.; Nemeroff, C. B. Corticotropin-releasing factor as a possible cause of comorbidity in anxiety and depressive disorders. In: Maser J. D.; Cloninger, C. R., eds. Comorbidity of mood and anxiety disorders. Washington DC: American Psychiatric Press, 1988:413-435.
4. 1A agonists in anxiety and depression. J. Psychopharmacology 7:283-289; 1993.
5. Drugan, R. C.; Maier, S. F.; Skolnick, P. An anxiogenic benzodiazepine receptor ligand induces learned helplessness. Eur J. Pharmacol. 113:453-457; 1985.
6. Fahre, L. F. Buspirone in the management of major depression: A placebo controlled comparison. J. Clin. Psychiatr. 51:55-61; 1990.
7. Goldberg, R. J. Depression in primary care: DSM-III diagnoses and other depressive syndromes. J. Gen. Int. Med. 3:491-497; 1988.
8. Goldberg, R. J. Diagnostic dilemmas presented by patients with anxiety and depression. Am. J. Medicine 98:278-284; 1995.
9. Gulley, L. R.; Nemeroff, C. B. The neurobiological basis of mixed depression-anxiety states. J. Clin. Psychiatr. 54(Suppl. 1):16-19; 1993.
10. Holsboer, F.; Spengler, D.; Heuser, I. The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia. Prog. Brain Res. 93:385-417; 1992.
11. Holsboer, F.; Grasser, A.; Friess, E.; Wiedemann, K. Steroid effects on central neurons and implications for psychiatric and neurologic disorders. Ann. NY Acad. Sci. 746:345-361; 1994.
12. Kalimi, M.; Regelson, W. The biologic role of dehydroepiandrosterone. Berlin: Walter de Gruyter; 1990.
13. Lesse, S. The relationship of anxiety to depression. Am. J. Psychother. 36:332-349; 1982.
14. A-receptor. Mechanism of action and physiological significance. Prog Neurobiol 38:379-395; 1992.
15. Melchior, C. L.; Ritzman, R. F. Dehydroepiandrosterone is an anxiolytic in mice on the plus maze. Pharmacol. Biochem. Behav. 47:437-441; 1994.
16. Pare, W. P. The performance of WKY rats on three tests of emotional behavior. Physiol. Behav. 51:1051-1056; 1992.
17. Paul, S. M. Anxiety and depression: A common neurobiological substrate? J. Clin. Psychiatr. 49:(Suppl. 10):13-16; 1988.
18. Pellow, S.; Chopin, P.; File, S. E.; Briley, M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 14:149-167; 1985.
19. Petty, F.; Sherman, D. GABAergic modulation of learned helplessness. Pharmacol. Biochem. Behav. 15:567-570; 1981.
20. Porsolt, R. D.; Bertin, A.; Jalfre, M. Behavioral despair in mice: A primary screening test for antidepressants (abstr). Arch. Internat. Pharmacodyn. Ther. 229:327-336; 1977a.
21. Porsolt, R. D.; Le Pichon, M.; Jalfre, M. Depression: A new model sensitive to antidepressant treatments (abstr). Nature 266:730-732; 1977b.
22. Porsolt, R. D.; Anton, G.; Blavet, N.; Jalfre, M. Behavioral despair in rats: A new model sensitive to antidepressant treatments. Eur. J. Pharmacol. 47:379-391; 1978.
23. Prasad, A.; Henry, M.; Prasad, C. Heterogeneity in the performance of outbred Sprague-Dawley rats in an elevated-plus maze test: A possible animal model for anxiety disorder. Life Sci. 59:1499-1506; 1996.
24. Reus, V. I.; Wolkowitz, O. M.; Roberts, E.; Chan, T.; Turetsky, N.; Manfredi, F.; Weingartner, H. Dehydroepiandrosterone (DHEA) and memory in depressed patients (abstr). Neuropsychopharmacol. 9:66S; 1993.
25. Sapolsy, R. M.; Plotsky, P. M. Hypercortisolism and its possible neural basis. Biol. Psychiatr. 27:937-952; 1990.
26. Sherman, A. D.; Petty, F. Additivity of neurochemical changes in learned helplessness and imipramine. Behav. Neural. Biol. 35:344-353; 1982.
27. 3H] imipramine binding in rat cortex. J. Affective Disorder 6:25-32; 1984.
28. Stenzel-Poore, M. P.; Heinrichs, S. C.; Rivest, S.; Koob, G. F.; Vale, W. W. Overproduction of corticotropin-releasing factor in transgenic mice: A genetic model of anxiogenic behavior. J. Neuroscience 14: 2579-2584; 1994.
29. Thakore, J. H.; Dinan, T. G. Cortisol synthesis inhibition: A new treatment strategy for the clinical and endocrine manifestations of depression. Biol. Psychiatr. 37:364-368; 1995.
30. Wahlestedt, C.; Pich, E. M.; Koob, G. F.; Yee, F.; Heilig, F. Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science (Lond.) 259:528-531; 1993.
31. Weiss, J. M.; Goodman, P. A.; Losito, B. G.; Corrgan, S.; Charry, J. M.; Bailey, W. H. Behavioral depression produced by an uncontrollable stressor: Relationship to norepinephrine, dopamine, and serotonin levels in various regions of rat brain. Brain Res. 3:167-205; 1981.
32. Wetzler, S.; Katz, M. M. Problem with the differentiation of anxiety and depression. J. Psychiatr. Res. 23:1-12; 1981.
33. Wolkowitz, O. M.; Reus, V. I.; Roberts, E.; Manfredi, F.; Chan, T.; Ormiston, S.; Johnson, R.; Canick, J.; Brizendine, L.; Weingartner, H. Antidepressant and cognition-enhancing effects of DHEA in major depression. Ann. NY Acad. Sci. 774:337-339; 1995.